Universe Pharmaceuticals (UPC) Receives Staff Determination Notice from Nasdaq Related to Delayed Annual Report Feb 25, 2025 04:10PM
Universe Pharmaceuticals (UPC) Receives Nasdaq Delisting Notice Subject to Hearing Request Feb 3, 2025 04:10PM
Universe Pharmaceuticals (UPC) Announces $15 Million Registered Direct Offering Dec 9, 2024 07:01AM
Universe Pharmaceuticals (UPC) Announces 1:15 Share Consolidation Nov 13, 2024 08:02AM
Universe Pharmaceuticals (UPC) Receives Nasdaq Non-compliance Notice Nov 1, 2024 04:00PM